| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/GASTRO/GOX016 |
| P8608 | Fatcat ID | release_az4ildacq5efzi3d2wzdykb64i |
| P932 | PMC publication ID | 5806393 |
| P698 | PubMed publication ID | 29479441 |
| P2093 | author name string | Jieshou Li | |
| Yi Li | |||
| Jianfeng Gong | |||
| Weiming Zhu | |||
| Zhen Guo | |||
| Chao Ding | |||
| Yao Wei | |||
| Tenghui Zhang | |||
| Tingbin Xie | |||
| Xujie Dai | |||
| P2860 | cites work | Predictive factors of response to cyclosporine in steroid-refractory ulcerative colitis | Q33307776 |
| Reliability and initial validation of the ulcerative colitis endoscopic index of severity | Q34870256 | ||
| A systematic review of the measurement of endoscopic healing in ulcerative colitis clinical trials: recommendations and implications for future research | Q35169255 | ||
| The Impact of Clinical Information on the Assessment of Endoscopic Activity: Characteristics of the Ulcerative Colitis Endoscopic Index Of Severity [UCEIS]. | Q35625694 | ||
| Mortality associated with medical therapy versus elective colectomy in ulcerative colitis: a cohort study | Q37047522 | ||
| The Ulcerative Colitis Endoscopic Index of Severity More Accurately Reflects Clinical Outcomes and Long-term Prognosis than the Mayo Endoscopic Score | Q37118462 | ||
| Agreement Between Rectosigmoidoscopy and Colonoscopy Analyses of Disease Activity and Healing in Patients With Ulcerative Colitis | Q40364553 | ||
| Delayed surgery for acute severe colitis is associated with increased risk of postoperative complications | Q43184169 | ||
| Predictive factors of outcome of intensive intravenous treatment for attacks of ulcerative colitis | Q44970862 | ||
| Fecal calprotectin predicts the clinical course of acute severe ulcerative colitis. | Q45926125 | ||
| Does infliximab influence surgical morbidity of ileal pouch-anal anastomosis in patients with ulcerative colitis? | Q46840604 | ||
| Level of Fecal Calprotectin Correlates With Endoscopic and Histologic Inflammation and Identifies Patients With Mucosal Healing in Ulcerative Colitis. | Q50547468 | ||
| The Modified Mayo Endoscopic Score (MMES): A New Index for the Assessment of Extension and Severity of Endoscopic Activity in Ulcerative Colitis Patients. | Q51012059 | ||
| Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial. | Q53122367 | ||
| Association between the ulcerative colitis endoscopic index of severity (UCEIS) and outcomes in acute severe ulcerative colitis. | Q53579269 | ||
| Early predictors of glucocorticosteroid treatment failure in severe and moderately severe attacks of ulcerative colitis. | Q54115144 | ||
| Predicting the outcome of severe ulcerative colitis: development of a novel risk score to aid early selection of patients for second-line medical therapy or surgery. | Q54563945 | ||
| Segundo Consenso Europeo basado en evidencia sobre el diagnóstico y tratamiento de la colitis ulcerosa crónica idiopática Parte 1: Definiciones y diagnóstico (versión española) | Q57265313 | ||
| Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study | Q68206432 | ||
| Infliximab in ulcerative colitis is associated with an increased risk of postoperative complications after restorative proctocolectomy | Q81416000 | ||
| Disease Extension Matters in Endoscopic Scores: UCEIS Calculated as a Sum of the Single Colonic Segments Performed Better than Regular UCEIS in Outpatients with Ulcerative Colitis | Q87311009 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 38-44 | |
| P577 | publication date | 2017-04-26 | |
| P1433 | published in | Gastroenterology report | Q27725210 |
| P1476 | title | Ulcerative Colitis Endoscopic Index of Severity (UCEIS) versus Mayo Endoscopic Score (MES) in guiding the need for colectomy in patients with acute severe colitis. | |
| P478 | volume | 6 |
| Q90262218 | Impaired neurocognitive and psychomotor performance in patients with inflammatory bowel disease |
| Q91817020 | Management of Acute Severe Colitis in the Era of Biologicals and Small Molecules |
| Q99638642 | Potential for Standardization and Automation for Pathology and Endoscopy in Inflammatory Bowel Disease |
| Q89944305 | Serum Catestatin Levels and Arterial Stiffness Parameters Are Increased in Patients with Inflammatory Bowel Disease |
| Q96229726 | Serum adropin levels are reduced in patients with inflammatory bowel diseases |
| Q94093775 | UEG Week 2018 Poster Presentations |
| Q98892428 | Vedolizumab for ulcerative colitis: Real world outcomes from a multicenter observational cohort of Australia and Oxford |
Search more.